Thaddaus C. Strzalkowski
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retrovirus-based manufacturing of chimeric antigen receptor-modified T cells for cancer therapy research.
Journal: Methods in cell biology
Published: January 17, 2025
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
Journal: Nature biomedical engineering
Published: March 19, 2024
Correction to: CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
Journal: Cancer immunology, immunotherapy : CII
Published: May 08, 2023
9th Immunotherapy of Cancer conference (ITOC): A meeting report.
Journal: Human vaccines & immunotherapeutics
Published: December 28, 2022
CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
Journal: Cancer immunology, immunotherapy : CII
Published: December 18, 2022
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
Journal: British journal of cancer
Published: July 29, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026